je.st
news
UPDATE 5-Pfizer's Allergan deal teeters on new U.S. inversion curbs
2016-04-06 03:35:30| Waste Management - Topix.net
U.S. drug maker Pfizer Inc's $160 billion agreement to acquire Botox maker Allergan Plc was on the brink of being abandoned on Tuesday, after the U.S. Treasury issued new rules on how tax "inversion" deals can be structured. Allergan's shares were hit considerably hard on Tuesday, showing how the rules that were issued on Monday targeted the biggest inversion attempted to date.
Tags: update
deal
inversion
curbs
Category:Energy and Environment